University of Oklahoma researcher awarded NIH grant to advance tribally defined approaches to genomic research
Grant and Award Announcement
Updates every hour. Last Updated: 30-May-2026 22:15 ET (31-May-2026 02:15 GMT/UTC)
A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout.
The new research, which is published in JAMA Internal Medicine, shows that treating gout to target blood urate levels also prevents heart attacks and stroke. The study is led by Professor Abhishek from the School of Medicine at the University along with colleagues at Keele University and London School of Hygiene & Tropical Medicine in the UK, Gothenburg University in Sweden, and Polytechnic University of Marche in Italy.
A coalition of leading international experts in nephrology, bone health, and musculoskeletal disease has released the first comprehensive Consensus Statement on the Management of Vertebral Fractures in Chronic Kidney Disease (CKD) Stages G4–G5D. The statement highlights a neglected yet devastating complication of advanced kidney disease: skeletal fragility and vertebral fractures.
Published in Nephrology Dialysis Transplantation, the Consensus is a joint initiative of the International Osteoporosis Foundation (IOF) Skeletal Fragility–Chronic Kidney Disease (SKY-CKD) Working Group, the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO), the European Renal Association (ERA) CKD-MBD Working Group, and the European Renal Osteodystrophy (EUROD) group.
Researchers from Northwestern University and Ann & Robert H. Lurie Children’s Hospital of Chicago have developed the first device that can continuously track a fetus’s vital signs while still in the uterus — a feat that previously has not been possible.